RxDoctor Payments DataLook up a doctor →

Waseem Ahmad, MD

Neurology · Davenport, IANPI 1124063375

Payments from drug & device makers

$17,172in general payments, 2019–2025

Across 596 payments — averaging $28.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$3K
  • Globus Medical$2K
  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Livanova USA, Inc.$1K
  • Harmony Biosciences LLC$865
  • plus $7K from 46 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer30$3,228
Globus Medical3$2,072
AbbVie(2 entities)76$1,317
Teva Pharmaceuticals USA, Inc.47$1,115
Livanova USA, Inc.16$1,093
Harmony Biosciences LLC59$865
Novartis40$698
Jazz Pharmaceuticals Inc.22$615
Biogen29$529
UCB, Inc.18$446
Lilly USA, LLC20$421
Lundbeck LLC18$418
Sanofi16$380
Neurocrine Biosciences, Inc.17$299
Supernus Pharmaceuticals, Inc.20$288
Acadia Pharmaceuticals Inc22$284
Eisai Inc.14$278
Amgen15$264
Argenx US, Inc.8$252
Kyowa Kirin, Inc.9$178
Otsuka America Pharmaceutical, Inc.9$170
AstraZeneca8$167
Johnson & Johnson(2 entities)5$163
Boston Scientific3$156
Genentech USA, Inc.7$143
Biohaven Pharmaceuticals, Inc.7$133
Itamar Medical Inc1$129
MDD US Operations, LLC8$119
Sumitomo Pharma America, Inc.6$117
Inspire Medical Systems, Inc.1$91
Biohaven Pharmaceutical Holding Company Ltd.5$89
Axsome Therapeutics, Inc.4$79
Medtronic(2 entities)3$61
Sunovion Pharmaceuticals Inc.4$50
Upsher-smith Laboratories LLC3$45
Avion Pharmaceuticals2$40
Impel Pharmaceuticals Inc.2$40
Mallinckrodt Hospital Products Inc.2$35
Merz Pharmaceuticals, LLC2$34
Resmed Corp1$31
Ceribell, Inc.1$30
Tanabe Pharma America, Inc.2$30
Avanir Pharmaceuticals, Inc.1$28
Xeris Pharmaceuticals, Inc.2$26
Catalyst Pharmaceuticals, Inc.1$25
Acorda Therapeutics, Inc1$17
Amneal Pharmaceuticals LLC1$17
Philips North America LLC1$15
Abbott1$14
Bristol Myers Squibb1$13
Mylan Specialty L.p.1$12
E.r. Squibb & Sons, L.L.C.1$12

How this compares

$17,172 in reported general payments places this provider in the 80th percentile of 132 neurology providers in Iowa.

See all neurology providers in Iowa →

Medicare billing

Part B allowed, 2024
$198,284
Medicare patients
464
Services billed
745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Davenport

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →